This stands in stark contrast to observations in lung cancer, that indicated lowered Sep15 expression to correlate with higher cancer incidence [23], and, while exactly why this discrepancy exists is subject to further study, it points to a possibly strong tissue-specificity in terms of the role of Sep15. Here, SELENOF is linked to lung cancer.